Hydroxychloroquine denied due to quantity / dose limits by Humana?

Humana's specific coverage criteria for hydroxychloroquine are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Applied Quantity Limits to Hydroxychloroquine — and How to Appeal

Quantity limit (QL) denials for hydroxychloroquine (HCQ) occur when the amount prescribed — measured by number of tablets, days' supply, or total dosage per fill — exceeds the quantity Humana's plan allows without additional authorization. For HCQ, quantity limits are often tied to weight-based dosing guidance in the FDA prescribing label, and Humana's system may flag prescriptions that appear to exceed that guidance.

This type of denial is very commonly resolved on appeal, particularly when the prescribing physician documents a clinical reason for the prescribed quantity — such as patient weight, severity of disease, documented tolerability, or an unusual dosing schedule recommended by a specialist.

## Your Federal Appeal Rights

• Internal appeal: Under ERISA §503 and ACA §2719, Humana must provide a full-and-fair internal review. Submit your appeal in writing within the timeframe stated on the denial letter (commonly 180 days from denial).
• External review: If internal appeal is unsuccessful, ACA §2719 provides access to an Independent Review Organization (IRO). You typically have four months (180 days) from a final adverse determination to file.
• Expedited review: Available if delay would seriously jeopardize health. Humana must decide within 72 hours on an expedited internal appeal.

## Documentation to Gather

1. Prescriber justification letter — a letter from your treating physician explaining the rationale for the specific quantity prescribed, referencing your documented weight, disease severity, and any specialty guideline organization (e.g., ACR) recommendations that support the regimen. 2. FDA prescribing information — a copy of the current FDA-approved HCQ label to demonstrate that the prescribed quantity is consistent with or within the range of labeled dosing guidance. Direct Humana to the relevant section rather than asserting a specific number yourself. 3. Diagnosis and disease severity documentation — chart notes confirming the active diagnosis, clinical severity (e.g., disease activity indices documented by your specialist), and why the current quantity is clinically necessary. 4. Humana's quantity limit policy — request the exact quantity limit criteria from Humana's drug policy so the appeal directly addresses each stated threshold and rationale. 5. Prior fill history — pharmacy records showing any prior fills at the same quantity, if applicable, to demonstrate established clinical use without adverse outcomes.

## Criteria-Mapping Structure

Address Humana's quantity limit criteria one by one. For each restriction, cite the specific clinical fact that justifies an exception: "Criterion: quantity limit of [per Humana policy] — Exception basis: prescriber letter dated [date] documents patient weight of [X kg] per chart, placing prescribed dose within FDA label guidance as cited." Keep the argument grounded in the prescribing label language and the physician's documented clinical judgment.